Validations: Filing-Grade Defensibility & Lifecycle
E&L Storyboards for Inspections and HA Meetings Introduction to Extractables and Leachables (E&L) In the pharmaceutical industry, the safety and efficacy of drug formulations are paramount. As these formulations come into contact with various materials during their lifecycle, understanding the potential risks posed by extractables and leachables (E&L) is crucial. Extractables are the substances that can be extracted from packaging…
Top Filing Pitfalls in E&L—and How to Avoid Them Top Filing Pitfalls in E&L—and How to Avoid Them Introduction to Extractables and Leachables (E&L) The significance of extractables and leachables (E&L) in the pharmaceutical industry cannot be overstated. With the increasing use of single-use systems, the concern surrounding compounds that might leach from packaging materials into pharmaceutical products has escalated….
Internal Peer Review Checklists for E&L Packages The pharmaceutical industry faces stringent regulations around extractables and leachables (E&L) assessments to ensure product quality and patient safety. This step-by-step tutorial provides an in-depth guide to developing internal peer review checklists for E&L packages, emphasizing the significance of analytical evaluation thresholds (AET) and dose-based thresholds (DBT) for effective packaging qualification. Understanding Extractables…
KPIs for Filing Readiness: Are You Truly Ready? In the rapidly evolving pharmaceutical landscape, ensuring compliance with Good Manufacturing Practices (cGMP) is critical for regulatory success. One of the key areas of focus is the evaluation of extractables and leachables (E&L), particularly in the context of filing readiness. This comprehensive guide aims to outline the key performance indicators (KPIs) associated…
Creating a Reusable E&L Knowledge Base Across Sites Creating a Reusable E&L Knowledge Base Across Sites Introduction to Extractables and Leachables (E&L) Extractables and leachables (E&L) are critical components in the pharmaceutical industry, particularly in the context of process validation and product integrity. They represent chemical compounds that can migrate from packaging or container closure systems into drug products, thereby…
Dossier Templates: Module 3 Placement and Cross-Refs Understanding the Importance of Extractables and Leachables in Pharmaceutical Packaging In the pharmaceutical industry, ensuring the safety and efficacy of drugs is paramount. A key component of this process is understanding extractables and leachables (E&L), which are compounds that can migrate from packaging components into pharmaceutical products. This understanding is crucial for compliance…
Lifecycle: Periodic Review and Triggers for Re-Work This comprehensive guide provides an in-depth examination of the lifecycle of extractables and leachables (E&L) within the context of pharmaceutical manufacturing. It describes periodic review processes and establishes criteria for re-work that adheres to regulatory frameworks from the FDA, EMA, MHRA, and other international bodies. Understanding Extractables and Leachables Extractables and leachables are…
Using CPV to Track Packaging Risks Over Time Introduction to Extractables and Leachables in Pharmaceutical Packaging In the pharmaceutical industry, packaging serves as the first line of defense for maintaining the integrity of the product, ensuring that active ingredients remain effective until administration. The concerns surrounding extractables and leachables (E&L) have escalated, especially in light of regulatory scrutiny from authorities…
Defending AET/DBT Choices Under Scrutiny Defending AET/DBT Choices Under Scrutiny Extractables and leachables (E&L) testing is critical for ensuring the safety and efficacy of pharmaceutical products. As regulatory scrutiny increases, professionals in the pharmaceutical and biopharmaceutical industries must not only understand the concepts of Analytical Evaluation Threshold (AET) and Dose-Based Threshold (DBT) but also how to defend these choices against…
Ensuring Method Sensitivity vs AET: Evidence Packs The pharmaceutical industry faces increasing scrutiny regarding the safety and efficacy of products, specifically in relation to extractables and leachables (E&L) and their impact on drug quality. Method sensitivity, particularly in the context of analytical evaluation thresholds (AET) and dose-based thresholds (DBT), is pivotal in demonstrating compliance with regulatory expectations. This article serves…